Portolan Capital Management’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
Portolan Capital Management's PLSE Position: Q3 2026 in Review
Portolan Capital Management reduced its Pulse Biosciences (PLSE) stake by 62% in Q3 2026, selling an estimated $19.6M and leaving 288,356 shares worth $14.4M. The position accounts for 0.59% of the portfolio, ranked #61.
Portolan Capital Management first reported a position in PLSE in Q3 2025 and has held it in 5 quarters since. The position peaked at $20.9M in Q2 2026. 142 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.
- Portolan Capital Management held 288,356 shares of Pulse Biosciences worth $14.4M as of Q3 2026.
- Portolan Capital Management sold 464,977 Pulse Biosciences shares in Q3 2026, an estimated $19.6M.
- Pulse Biosciences made up 0.59% of Portolan Capital Management's portfolio in Q3 2026, its #61 holding.
- Portolan Capital Management first reported a position in Pulse Biosciences in Q3 2025 and has held it in 5 quarters since.
- Portolan Capital Management's Pulse Biosciences position peaked at $20.9M in Q2 2026.
- 142 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.
Based on Portolan Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.